PRL-8-53 Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: PRL-8-53 evidence and protocol review

Nootropic Compounds compound PowderLiquid Community-Supported (not scientifically verified)

Also known as: Methyl 3-(2-benzylmethylaminoethyl) benzoate

Community-Supported: unlocked based on forum/Reddit discussion, NOT on peer-reviewed or scientific verification. This content is for research and educational reference only. These compounds, protocols, and dosing figures are not verified, may not be FDA-approved, and are not intended for use in humans or animals. Always independently verify before relying on any of this information.

Quick Facts

Reference Sizes
100 mg, 500 mg, 1 g
Storage
No approved product standard; research powder requires identity, purity, and stability documentation
Solubility
Slightly water-soluble; dissolve in warm water or ethanol

Catalog Description

PRL-8-53 is a synthetic compound from the 1970s studied for memory enhancement. The sole published human trial (1978, Psychopharmacology) reported enhanced learning and subsequent retention at low oral doses (100-200% improvement in retention reported at a 5mg dose). This remains the only known human study of PRL-8-53 - it has not been independently replicated in the nearly five decades since, which should be weighted heavily when assessing the strength of evidence behind this compound relative to others in this catalog with more extensive trial histories.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Not established in humans beyond the timing of the single 1978 experiment
Onset
Effects reported within the single-dose study window (hours) in the original trial
Administration Routes (Research)
Oral in the sole published human study; sublingual community use is not a tested route

Reported Research Effects

Reported Research Side Effects

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

The record now ties the 5 mg amount to the actual single-session experiment. It does not support daily use, escalation, stacking, or a general nootropic protocol.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

PRL-8-53 human verbal-learning study — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/418433/

Community Discussion Unverified

Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.

Community discussion of PRL-8-53 is limited but generally describes subjective short-term memory/recall benefits; a few users report anxiety-like overstimulation at higher doses. Anecdotal, not clinically verified against modern safety standards.

My experience with PRL-8-53 (r/Biohackers)
https://www.reddit.com/r/Biohackers/comments/15m5icd/my_experience_with_prl853/

User reports a first-hand trial describing subjective memory/recall effects; single self-reported account.

TAK-653 with PRL-8-53 dosage, side effects, experiences (r/NooTopics)
https://www.reddit.com/r/NooTopics/comments/10pe8fo/tak653_with_prl853_dosage_side_effects_experiences/

Community discussion of combined TAK-653/PRL-8-53 use, dosage, and side effects; anecdotal, self-reported.

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top